QA: Tempest Therapeutics Inc. in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001544227_2017_Tempest_Therapeutics_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001544227, Tempest Therapeutics Inc.

  xvar xval
0 AssetsCurrent 116,444,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 5,572,000
3 remainder_Assets 527,000
4 LiabilitiesCurrent 13,209,000
5 LiabilitiesNoncurrent 1,116,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 5,401,000
8 SellingGeneralAndAdministrativeExpense 49,223,000
9 ResearchAndDevelopmentExpense 21,641,000
10 remainder_Expenses 5,601,000
11 remainder_Revenues 653,000
12 remainder_NetIncome -1,047,000
13 remainder_ComprehensiveNetIncome 110,000
  yvar yval
0 Assets 122,543,000
1 Liabilities 14,325,000
2 Expenses 81,866,000
3 Revenues 653,000
4 StockholdersEquity 108,218,000
5 NetIncome -82,260,000
6 ComprehensiveNetIncome -82,205,000
7 BaseVar 110,272,000
8 EconomicCapitalRatio 1.52

Edgar->Model Mapping

Feature Distribution